CHECKPOINT THERAPEUTICS
Dead / Abandoned — Abandoned — no statement of use filed (as of 17 Sept 2018)
What this means for you
This application is over — abandoned 17 Sept 2018. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86498366
- Mark type
- Stylized text
- Filed
- 08 Jan 2015
- Published for opposition
- 16 Jun 2015
- Abandoned
- 17 Sept 2018
- Attorney of record
- Devon E. White
Goods and services
- Class 005 — Pharmaceuticals: Medical, biological and pharmaceutical preparations for scientific, research, medical or pharmaceutical use, namely, preparations for the treatment of cancer, autoimmune diseases and disorder, rare diseases, genetic diseases, infectious diseases, central nervous system infections, gastrointestinal infections, genitourinary infections, ocular infections, dermatological infections, immune system infections, liver infections, hepatic infections, neurological disorders, tuberculosis, lung diseases, asthma, hypertension, cardiovascular diseases, immunologic diseases, immunologic deficiency syndromes, tumors, proliferative diseases, inflammatory diseases, inflammatory bowel diseases, inflammatory connective tissue diseases, psoriasis, ophthalmologic diseases, fibrotic diseases, metabolic diseases, dental and oral diseases, neurological diseases, Alzheimer´s disease, Huntington´s disease, Parkinson, cerebral palsy, brain injury, spinal cord injury, seizure disorders, congenital disorders, metabolic disorders, viral and infectious diseases and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of genetic and congenital disorders, metabolic disorders, infectious diseases, cancer and pain relief; Pharmaceutical products for the treatment and normalization of disorders of the body's circulatory system; Pharmaceutical products for the treatment of diseases of the blood or of the lymphatic circulatory system; Pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
Owner
- Checkpoint Therapeutics, Inc., New York, NY, US
- Checkpoint Therapeutics, Inc., New York, NY, US
Prosecution history
- 17 Sept 2018 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 17 Sept 2018 — ABANDONMENT - NO USE STATEMENT FILED
- 24 Jul 2018 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 24 Jul 2018 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 06 Feb 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Feb 2018 — SOU EXTENSION 5 GRANTED
- 02 Feb 2018 — SOU EXTENSION 5 FILED
- 02 Feb 2018 — SOU TEAS EXTENSION RECEIVED
- 12 Aug 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Aug 2017 — SOU EXTENSION 4 GRANTED
- 10 Aug 2017 — SOU EXTENSION 4 FILED
- 10 Aug 2017 — SOU TEAS EXTENSION RECEIVED
- 14 Jan 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Jan 2017 — SOU EXTENSION 3 GRANTED
- 12 Jan 2017 — SOU EXTENSION 3 FILED